NEW YORK (Reuters Health) - The European market for therapeutic hypothermia devices was US$217 million in 2006, according to Frost & Sullivan. By 2012, it is estimated to reach US$543 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results